InvestorsHub Logo
Followers 34
Posts 4311
Boards Moderated 0
Alias Born 07/16/2014

Re: falconer66a post# 130284

Monday, 11/13/2017 1:18:35 PM

Monday, November 13, 2017 1:18:35 PM

Post# of 470920
“Agonist of the intracellular sigma-1 chaperone protein. It is a mixed ligand for sigma-1 and muscarinic cholinergic receptors. It has shown anti amnesic and neuroprotective effects in preliminary studies and also has a clean Phase 1 clinical data”


Page 8 (370)

https://www.researchgate.net/profile/Abhinav_Anand23/publication/320161874_The_present_and_future_of_pharmacotherapy_of_Alzheimer%27s_disease_A_comprehensive_review/links/59f2917ba6fdcc1dc7bb1c28/The-present-and-future-of-pharmacotherapy-of-Alzheimers-disease-A-comprehensive-review.pdf


Think this one might be worth watching...?

MK-7622 / Phase 3. Muscarinic M4 receptor modulator
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News